Clinical Evaluation of the New Hypoxia Imaging Agent HX4

NCT01213030 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer
Lung Cancer
Liver Cancer

Interventions

DRUG: [F-18] FMISO
DRUG: [F-18] HX4

Sponsor

Siemens Molecular Imaging

Collaborators

[object Object]